Search Results - "Deighan, Christopher J"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Comparison of Urinary Albumin and Urinary Total Protein as Predictors of Patient Outcomes in CKD by Methven, Shona, MB, ChB, MacGregor, Mark S., FRCP (Glas), Traynor, Jamie P., MD, Hair, Mario, MPhil, O'Reilly, Denis St J., MD, Deighan, Christopher J., MD

    Published in American journal of kidney diseases (01-01-2011)
    “…Background Proteinuria is common and is associated with adverse patient outcomes. The optimal test of proteinuria to identify those at risk is uncertain. This…”
    Get full text
    Journal Article
  2. 2

    A Cognitive Behavioral Group Approach to Enhance Adherence to Hemodialysis Fluid Restrictions: A Randomized Controlled Trial by Sharp, John, Wild, Matt R., Gumley, Andrew I., Deighan, Christopher J.

    Published in American journal of kidney diseases (01-06-2005)
    “…Background: Adhering to fluid restrictions represents one of the most difficult aspects of the hemodialysis treatment regimen. This report describes a…”
    Get full text
    Journal Article
  3. 3

    Obstetric and long-term kidney outcomes in renal transplant recipients: a 40-yr single-center study by Stoumpos, Sokratis, McNeill, Susan H., Gorrie, Morag, Mark, Patrick B., Brennand, Janet E., Geddes, Colin C., Deighan, Christopher J.

    Published in Clinical transplantation (01-06-2016)
    “…Female renal transplant recipients of childbearing age may ask what the outcomes are for pregnancy and whether pregnancy will affect graft function. We…”
    Get full text
    Journal Article
  4. 4

    Assessing proteinuria in chronic kidney disease: protein–creatinine ratio versus albumin–creatinine ratio by Methven, Shona, MacGregor, Mark S., Traynor, Jamie P., O’Reilly, Denis St J., Deighan, Christopher J.

    Published in Nephrology, dialysis, transplantation (01-09-2010)
    “…Background. Quantification of proteinuria is important in the assessment of chronic kidney disease (CKD). The aim of this study was to investigate the optimal…”
    Get full text
    Journal Article
  5. 5

    Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease by DEIGHAN, Christopher J, CASLAKE, Muriel J, MCCONNELL, Michael, BOULTON-JONES, J. Michael, PACKARD, Christopher J

    “…Patients with nephrotic-range proteinuria have impaired clearance of triglyceride-rich lipoproteins. This results in the atherogenic lipoprotein phenotype…”
    Get full text
    Journal Article
  6. 6

    Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure by TRAYNOR, Jamie P, SIMPSON, Keith, GEDDES, Colin C, DEIGHAN, Christopher J, FOX, Jonathan G

    “…There is a trend to start dialysis earlier in patients with chronic renal failure. Studies that suggest improved survival from earlier initiation of dialysis…”
    Get full text
    Journal Article
  7. 7

    The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria by Bell, Samira, Cooney, Josephine, Packard, Christopher J, Caslake, Muriel J, Deighan, Christopher J

    Published in Clinical nephrology (01-06-2012)
    “…Patients with nephrotic range proteinuria are known to have an increased risk of cardiovascular disease partly due to possessing the atherogenic lipoprotein…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria by Bell, Samira, Cooney, Josephine, Packard, Christopher J, Caslake, Muriel, Deighan, Christopher J

    Published in Atherosclerosis (01-07-2009)
    “…Abstract Background Patients with nephrotic range proteinuria have a marked increase in the risk of cardiovascular disease. Qualitative and quantitative…”
    Get full text
    Journal Article
  10. 10

    Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation by Deighan, Christopher J., Caslake, Muriel J., McConnell, Michael, Boulton-Jones, J.Michael, Packard, Christopher J.

    Published in American journal of kidney diseases (01-05-2000)
    “…End-stage renal failure (ESRF) is associated with dyslipidemia and accelerated atherosclerosis. Triglyceride-rich lipoproteins accumulate and qualitative…”
    Get full text
    Journal Article
  11. 11

    Factors Predicting Outcome in a Cohort of Patients With Atherosclerotic Renal Artery Disease Diagnosed by Magnetic Resonance Angiography by Siddiqui, Samira, MacGregor, Mark S., Glynn, Catherine, Roditi, Giles, Deighan, Christopher J.

    Published in American journal of kidney diseases (01-12-2005)
    “…Background: Atherosclerotic renal artery disease increasingly is recognized as a cause of chronic kidney disease and associated with high morbidity and…”
    Get full text
    Journal Article
  12. 12

    Endothelial function in patients with proteinuric primary glomerulonephritis by Mackinnon, Bruce, Deighan, Christopher J, Ferrell, William R, Sattar, Naveed, Fox, Jonathan G

    Published in Nephron. Clinical practice (01-01-2008)
    “…Cardiovascular disease is the commonest cause of mortality among patients with end-stage renal disease. Endothelial function and inflammation have previously…”
    Get more information
    Journal Article
  13. 13

    The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria by Deighan, Christopher J., Caslake, Muriel J, McConnell, Michael, Boulton-Jones, J.Michael, Packard, Christopher J.

    Published in Atherosclerosis (01-07-2001)
    “…The dyslipidaemia in nephrotic-range proteinuria is believed to contribute to the increased atherogenesis associated with the condition. Excess small dense low…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1 by Deighan, Christopher J., Caslake, Muriel J., Mcconnell, Michael, Boulton-Jones, J. Michael, Packard, Christopher J.

    Published in Kidney international (01-09-2000)
    “…Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1. Impaired very low-density lipoprotein (VLDL) clearance contributes to…”
    Get full text
    Journal Article
  16. 16

    A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failure by MacGregor, Mark S, Deighan, Christopher J, Rodger, R Stuart C, Boulton-Jones, J Michael

    Published in Nephron. Clinical practice (01-01-2005)
    “…Treatment of hypertension slows the progression of non-diabetic nephropathies, but the optimal regimen is unknown. Angiotensin-converting enzyme inhibitors are…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Increased atherogenicity of low-density lipoprotein in heavy proteinuria by DEIGHAN, C. J, CASLAKE, M. J, MCCONNELL, M, BOULTON-JONES, J. M, PACKARD, C. J

    Published in Nephrology, dialysis, transplantation (01-05-1998)
    “…Heavy proteinuria is associated with marked abnormalities of lipoprotein metabolism and increased risk of atherogenesis. It is possible that qualitative as…”
    Get full text
    Journal Article
  19. 19

    The atherogenic lipoprotein phenotype in renal disease by Deighan, Christopher J

    Published 01-01-1999
    “…Nephrotic range proteinuria and chronic renal failure are associated with both qualitative and quantitative changes in lipoproteins and increased…”
    Get full text
    Dissertation